Discounting surgical benefits
- 1 December 1983
- journal article
- research article
- Published by Springer Nature in Journal of Medical Systems
- Vol. 7 (6) , 481-493
- https://doi.org/10.1007/bf00995179
Abstract
This manuscript introduces and demonstrates a modification of the popular cost-effectiveness methodology. Because arbitrarily selected discount rates for future health effects can radically change the cost-effect ratio, the determinants of the ratio—differences in the present values of effects and costs—are examined for a wide range of discount rates. Treatment selection then follows directly from explicit judgments about expected patient longevity and appropriate combinations of cost and effect discount rates. The decision to select resection or enucleation of a benign prostatic hypertrophy is developed with data from a small number of clinical patients from Washington University.Keywords
This publication has 10 references indexed in Scilit:
- Hypertension: a policy perspective, 1976–2008Journal of the American Society of Hypertension, 2009
- Cost Effectiveness of Lead ScreeningNew England Journal of Medicine, 1982
- Cost of capital, target rate of return, and investment decision making.1981
- Cost-Benefit and Cost-Effectiveness Analysis in Health CareMedical Care, 1980
- Cost-effective clinical decision makingPediatrics, 1977
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine, 1977
- Cost/benefit analysis of treatment and prevention of myocardial infarction.1977
- HypertensionPublished by Harvard University Press ,1976
- Medical treatment of benign prostatic hypertrophyPublished by Springer Nature ,1974
- The Incidence of Benign Prostatic ObstructionJournal of Urology, 1968